Botulinum Toxin
Cross-source consensus on Botulinum Toxin from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Benefits
Comparisons
Evidence quality
Highlighted claims
- The WIDE control arm does not receive botulinum toxin injection. — Intraoperative endoscopic pylorus dilatation during minimally invasive Ivor Lewis oesophagectomy to prevent delayed gastric conduit emptying (DGCE): protocol for the WIDE randomised controlled trial
- Botulinum toxin injection into the pylorus has been studied as a temporary way to reduce pyloric tone. — Intraoperative endoscopic pylorus dilatation during minimally invasive Ivor Lewis oesophagectomy to prevent delayed gastric conduit emptying (DGCE): protocol for the WIDE randomised controlled trial
- Meta-analyses have not shown a clear benefit of Botox for preventing delayed gastric conduit emptying. — Intraoperative endoscopic pylorus dilatation during minimally invasive Ivor Lewis oesophagectomy to prevent delayed gastric conduit emptying (DGCE): protocol for the WIDE randomised controlled trial
- The article presents botulinum toxin efficacy for preventing delayed gastric conduit emptying as debated because of variable responses and transient effects. — Intraoperative endoscopic pylorus dilatation during minimally invasive Ivor Lewis oesophagectomy to prevent delayed gastric conduit emptying (DGCE): protocol for the WIDE randomised controlled trial